SENORES PHARMACEUTICALS
Back to Income Statement
|
SENORES PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹59 Cr | ₹31 Cr | ₹84 Cr | ₹0.99 Cr | ₹0.99 Cr |
What is the latest Consolidated Net Profit of SENORES PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹59 Cr |
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹84 Cr |
| Mar2023 | ₹0.99 Cr |
| Mar2022 | ₹0.99 Cr |
How is Consolidated Net Profit of SENORES PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹59 Cr | 86.14 | |
| Mar2025 | ₹31 Cr | -62.69 | |
| Mar2024 | ₹84 Cr | 8,409.59 | |
| Mar2023 | ₹0.99 Cr | 0.00 | |
| Mar2022 | ₹0.99 Cr | - | |
Compare Consolidated Net Profit of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹5,799.8 Cr | -4.6% | -11.5% | 78.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | -4.6% |
-11.5% |
78.2% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses